FOLD - Amicus Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.64B
Enterprise Value 32.39B
Trailing P/E N/A
Forward P/E 1-14.32
PEG Ratio (5 yr expected) 1-0.17
Price/Sales (ttm)105.61
Price/Book (mrq)6.42
Enterprise Value/Revenue 395.63
Enterprise Value/EBITDA 6-12.06

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-806.48%

Management Effectiveness

Return on Assets (ttm)-15.78%
Return on Equity (ttm)-73.29%

Income Statement

Revenue (ttm)25.03M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)411.20%
Gross Profit (ttm)4.12M
EBITDA -198.49M
Net Income Avi to Common (ttm)-273.44M
Diluted EPS (ttm)-1.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)411.52M
Total Cash Per Share (mrq)2.47
Total Debt (mrq)161.64M
Total Debt/Equity (mrq)39.45
Current Ratio (mrq)6.32
Book Value Per Share (mrq)2.48

Cash Flow Statement

Operating Cash Flow (ttm)-173.7M
Levered Free Cash Flow (ttm)-136.51M

Trading Information

Stock Price History

Beta 1.16
52-Week Change 3202.43%
S&P500 52-Week Change 323.52%
52 Week High 316.60
52 Week Low 35.07
50-Day Moving Average 314.19
200-Day Moving Average 313.68

Share Statistics

Avg Vol (3 month) 32.31M
Avg Vol (10 day) 32.69M
Shares Outstanding 5166.27M
Float 135.61M
% Held by Insiders 10.67%
% Held by Institutions 1121.46%
Shares Short 331.83M
Short Ratio 312.32
Short % of Float 330.55%
Shares Short (prior month) 329.49M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A